Gronigen, The Netherlands. AGILeBiotics BV has raised the next series of investment for the development of novel antibiotics against multidrug-resistant infections. On 18th of July 2018, a deal was closed securing a joined investment from five regional investors, i.e. RUG Houdstermaatschappij BV, Stichting Ir. G.J. Smid Fonds BV, and Hanzepoort BV, Carduso Capital BV and Pharma Connect […]
Menu
